BACKGROUND: Previous studies reported that long-term exposure to traffic-related air pollution may increase the incidence of hypertension and diabetes. However, little is known about the associations of ultrafine particles (≤0.1 μm in diameter) with these two conditions. METHODS: We conducted a population-based cohort study to investigate the associations between exposures to ultrafine particles and nitrogen dioxide (NO2) and the incidence of diabetes and hypertension. Our study population included all Canadian-born residents aged 30 to 100 years who lived in the City of Toronto, Canada, from 1996 to 2012. Outcomes were ascertained using validated province-wide databases. We estimated annual concentrations of ultrafine particles and NO2 using land-use regression models and assigned these estimates to participants' annual postal code addresses during the follow-up period. Using random-effects Cox proportional hazards models, we calculated hazard ratios (HRs) and 95% confidence intervals (CIs) for ultrafine particles and NO2, adjusted for individual- and neighborhood-level covariates. We considered both single- and multipollutant models. RESULTS: Each interquartile change in exposure to ultrafine particles was associated with increased risk of incident hypertension (HR = 1.03; 95% CI = 1.02, 1.04) and diabetes (HR = 1.06; 95% CI = 1.05, 1.08) after adjusting for all covariates. These results remained unaltered with further control for fine particulate matter (≤2.5 μm; PM2.5) and NO2. Similarly, NO2 was positively associated with incident diabetes (HR = 1.06; 95% CI = 1.05, 1.07) after controlling for ultrafine particles and PM2.5. CONCLUSIONS: Exposure to traffic-related air pollution including ultrafine particles and NO2 may increase the risk for incident hypertension and diabetes. See video abstract at, http://links.lww.com/EDE/B337.
BACKGROUND: Previous studies reported that long-term exposure to traffic-related air pollution may increase the incidence of hypertension and diabetes. However, little is known about the associations of ultrafine particles (≤0.1 μm in diameter) with these two conditions. METHODS: We conducted a population-based cohort study to investigate the associations between exposures to ultrafine particles and nitrogen dioxide (NO2) and the incidence of diabetes and hypertension. Our study population included all Canadian-born residents aged 30 to 100 years who lived in the City of Toronto, Canada, from 1996 to 2012. Outcomes were ascertained using validated province-wide databases. We estimated annual concentrations of ultrafine particles and NO2 using land-use regression models and assigned these estimates to participants' annual postal code addresses during the follow-up period. Using random-effects Cox proportional hazards models, we calculated hazard ratios (HRs) and 95% confidence intervals (CIs) for ultrafine particles and NO2, adjusted for individual- and neighborhood-level covariates. We considered both single- and multipollutant models. RESULTS: Each interquartile change in exposure to ultrafine particles was associated with increased risk of incident hypertension (HR = 1.03; 95% CI = 1.02, 1.04) and diabetes (HR = 1.06; 95% CI = 1.05, 1.08) after adjusting for all covariates. These results remained unaltered with further control for fine particulate matter (≤2.5 μm; PM2.5) and NO2. Similarly, NO2 was positively associated with incident diabetes (HR = 1.06; 95% CI = 1.05, 1.07) after controlling for ultrafine particles and PM2.5. CONCLUSIONS: Exposure to traffic-related air pollution including ultrafine particles and NO2 may increase the risk for incident hypertension and diabetes. See video abstract at, http://links.lww.com/EDE/B337.
Authors: Mei Yang; Han Cheng; Chaowei Shen; Jie Liu; Hongkai Zhang; Jiyu Cao; Rui Ding Journal: Environ Sci Pollut Res Int Date: 2019-12-06 Impact factor: 4.223
Authors: Doug Brugge; Shir Lerman Ginzburg; Neelakshi Hudda; Linda Sprague Martinez; Leigh Meunier; Scott P Hersey; Ira Hochman; Douglas I Walker; Ben Echevarria; Mohan Thanikachalam; John L Durant; Wig Zamore; Misha Eliasziw Journal: Contemp Clin Trials Date: 2021-07-28 Impact factor: 2.261
Authors: Saeha Shin; Li Bai; Tor H Oiamo; Richard T Burnett; Scott Weichenthal; Michael Jerrett; Jeffrey C Kwong; Mark S Goldberg; Ray Copes; Alexander Kopp; Hong Chen Journal: J Am Heart Assoc Date: 2020-03-09 Impact factor: 5.501
Authors: Li Bai; Saeha Shin; Tor H Oiamo; Richard T Burnett; Scott Weichenthal; Michael Jerrett; Jeffrey C Kwong; Ray Copes; Alexander Kopp; Hong Chen Journal: Environ Health Perspect Date: 2020-08-12 Impact factor: 9.031